🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

6,867 results for “De” Clear

  1. Remsima 100 mg powder for concentrate for solution for infusion

    Disc Medicine

    Crohn's Disease

    approved small molecule active

    1 trial

  2. Reyanning mixture

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Tonsillitis

    approved small molecule active

    1 trial

  3. Rivastigmine transdermal patch

    Novartis Pharmaceuticals

    Alzheimer's Disease

    approved small molecule completed

    1 trial

  4. Rocuronium Bromide

    ELITE PHARMACEUTICALS INC /NV/

    Muscle Relaxation

    approved small molecule completed

    1 trial

  5. Roflumilast alternated days

    Lxo Ireland Designated Activity Company

    Chronic Obstructive Pulmonary Disease (COPD)

    approved small molecule completed

    1 trial

  6. Ropivacaine B. Braun 10 mg/ml injektionsvätska, lösning

    The George Institute

    lumbar arthrodesis

    approved small molecule active

    1 trial

  7. Rosuvastatin

    The First People's Hospital of Lianyungang

    Hyperlipidemia

    approved small molecule active

    1 trial

  8. Rosuvastatin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Infarction, Anterior Cerebral Artery

    approved small molecule active

    1 trial

  9. Rosuvastatin (5mg，10mg，20mg)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Carotid Atherosclerosis

    approved small molecule active

    1 trial

  10. SALINE, TRANEXAMIC ACID

    Disc Medicine

    Slipped capital femoral epiphysis (SCFE), Legg-Calvé-Perthes Disease (LCPD), Neuromuscular conditions, Secondary hip dysplasia, Developmental dysplasia of the hip (DDH)

    approved small molecule active

    1 trial

  11. SARS-CoV-2 Inactivated Vaccine

    Sinovac Research and Development Co.,

    COVID-19

    approved mab active

    2 trials

  12. SELPERCATINIB, SELPERCATINIB

    Eli Lilly Co.

    Non Small Cell Lung Cancer; Medullary Thyroid Cancer; Colon Cancer; Breast Cancer; Pancreatic Cancer; Papillary Thyroid Cancer; Other Solid Tumors With Evidence of Activating RET Alteration;

    approved small molecule active

    1 trial

  13. SEMAGLUTIDE, SEMAGLUTIDE, INSULIN GLARGINE, DAPAGLIFLOZIN

    Fondazione Telethon ETS

    type 2 diabetes

    approved small molecule active

    1 trial

  14. SILDENAFIL , LEVOTHYROXINE SODIUM

    The George Institute

    erectile function, hypothyroidism subclinic

    approved small molecule active

    1 trial

  15. SINECATECHINS

    The George Institute

    Anal high-grade squamous intraepithelial lesions (HSIL).

    approved small molecule active

    1 trial

  16. SODIUM CHLORIDE, Ondansetron Morningside 4 mg orodispergeerbare tabletten, Ondansetron 2 mg/ml Solution for Injection, Ketanest® S 5 mg/ml - Ampullen

    Shanghai Reinovax Biologics Co.,LTD

    Endometriosis

    approved small molecule active

    1 trial

  17. SODIUM CHLORIDE, ROPIVACAINE HYDROCHLORIDE

    Disc Medicine

    Total Hip Arthroplasty / THA

    approved small molecule active

    1 trial

  18. SPD489 (Lisdexamfetamine dimesylate)

    Takeda

    Attention-Deficit/Hyperactivity Disorder

    approved small molecule completed

    1 trial

  19. SPN-538

    SUPERNUS PHARMACEUTICALS, INC.

    Migraine Disorders

    approved small molecule terminated

    1 trial

  20. SPN-812

    SUPERNUS PHARMACEUTICALS, INC.

    Attention-Deficit/Hyperactivity Disorder (ADHD)

    approved small molecule completed

    1 trial

  21. SPN-812

    SUPERNUS PHARMACEUTICALS, INC.

    Attention-Deficit/Hyperactivity Disorder

    approved small molecule active

    3 trials

  22. SULPIRIDE , QUETIAPINE , PERPHENAZINE , CLOTIAPINE , ZIPRASIDONE , HALOPERIDOL , SERTINDOLE , PALIPERIDONE , ZUCLOPENTHIXOL , CARIPRAZINE , LEVOMEPROMAZINE , LURASIDONE , BREXPIPRAZOLE , AMISULPRIDE , CLOZAPINE , CHLORPROMAZINE , RISPERIDONE , FLUPHENAZINE , PROMAZINE , ARIPIPRAZOLE , ASENAPINE , OLANZAPINE , FLUPENTIXOL

    Disc Medicine

    schizophrenia, schizoaffective disorder, schizophrenifom disorder

    approved small molecule active

    1 trial

  23. Sabin-IPV and DTaP

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Vaccination

    approved mab active

    1 trial

  24. Sabin-IPV+bOPV+bOPV

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Vaccination

    approved mab completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources